Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharmasset research costs climb in 3Q loss
Yahoo/AP
Monday, July 25, 2011 - 7:38pm
tags:
Pharmasset, earnings
Bristol-Myers' Acquisition Could Pay for Itself
Motley Fool
Monday, July 25, 2011 - 7:37pm
tags:
M&A, Bristol-Myers Squibb, Amira
GSK sues Watson Pharma; buys back 1.6 million shares
Bizjournals.com
Monday, July 25, 2011 - 7:35pm
tags:
stock buyback, GSK, Watson Pharmaceuticals, lawsuits, Jalyn, benign prostatic hyperplasia
Whistleblower Lawsuit Against Amgen Is Reinstated
Pharmalot
Monday, July 25, 2011 - 1:38pm
tags:
Amgen, whistleblower lawsuits, kickbacks, False Claims Act, Medicaid, Medicare
Watson Pharmaceuticals Earnings Preview
Benzinga
Monday, July 25, 2011 - 1:36pm
tags:
Watson Pharmaceuticals, earnings
EnVivo, Backed by Fidelity Biosciences, Tests New Weapon Against Alzheimer’s
Xconomy
Monday, July 25, 2011 - 1:32pm
tags:
EnVivo, Fidelity Biosciences, Alzheimer's disease, EVP-0962
Drug prices to plummet in wave of expiring patents
Yahoo/AP
Monday, July 25, 2011 - 1:29pm
tags:
drug prices, patents, generics
Human Genome Incurs Wider Loss
Yahoo/Zacks.com
Monday, July 25, 2011 - 1:27pm
tags:
Human Genome Sciences, earnings
Will pharma fight the Express-Medco deal?
Fierce Pharma
Monday, July 25, 2011 - 12:02pm
tags:
Express Scripts, Medco, M&A, PBMs
Bristol-Myers Squibb Co. Second Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Monday, July 25, 2011 - 11:53am
tags:
earnings, Bristol-Myers Squibb
4-Star Stocks Poised to Pop: Amarin
Motley Fool
Monday, July 25, 2011 - 10:51am
tags:
Amarin
Biogen wins conditional EU approval for MS drug
Bizjournals.com
Monday, July 25, 2011 - 10:25am
tags:
Biogen Idec, Europe, MS, multiple sclerosis, Fampyra
Broker offers protection to pharma groups
FT.com
Monday, July 25, 2011 - 10:24am
tags:
regulatory inspections, inspections, business insurance
IPO Preview: Horizon Pharma
Seeking Alpha
Monday, July 25, 2011 - 10:18am
tags:
IPOs, Horizon Pharma
Johnson & Johnson: Decades of Dividends and Upside Potential
Seeking Alpha
Monday, July 25, 2011 - 10:17am
tags:
JNJ, dividends
3 Biotech Stocks Predictive Analysts Expect to Outperform
Seeking Alpha
Monday, July 25, 2011 - 9:41am
tags:
Immunogen, InterMune, Regeneron
Key blockbuster drugs about to get generic rivals
Yahoo/AP
Monday, July 25, 2011 - 9:10am
tags:
generics, Eli Lilly, Forest Labs, Pfizer, AstraZeneca, Cephalon, Bristol-Myers Squibb, Sanofi, patents, Abbott Laboratories, Merck, Takeda, Novartis, Endo, GSK
Anti-Coagulant Blockbuster Drugs Are Here
Seeking Alpha
Monday, July 25, 2011 - 9:08am
tags:
anticlotting, blood thinners, JNJ, Pfizer, AstraZeneca, Bristol-Myers Squibb, Bayer, Xarelto, Pradaxa, Boehringer Ingelheim, Eliquis
SuperGen completes acquisition of Astex Therapeutics
Pharmabiz
Saturday, July 23, 2011 - 4:54pm
tags:
Supergen, Astex, M&A
Glaxo pharmaceuticals will price its drugs 25-40% cheaper in India
DNA India, India
Saturday, July 23, 2011 - 4:51pm
tags:
GSK

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.